Home Home Home Inbox Home Search

Event

Long-Term Safety of Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA Study [Board No. P892]

Location: Board no. P892
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Robert Price

MSc
GlaxoSmithKline;GSK

Martyn J. Gilson

MSc
GSK

Frank C. Albers

MD, PhD
GlaxoSmithKline;GSK

Sumita Bhattacharya. Khatri

MD, MS
Cleveland Clinic Foundation;Cleveland Clinic Respiratory Inst

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

Hector Ortega

MD, ScD
GlaxoSmithKline;GSK

Richard Leigh

MD, PhD
Cumming School of Medicine, University of Calgary;University of Calgary

View Abstract

Long-Term Safety of Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA Study

Parent Sessions

  • A34 - ASTHMA CLINICAL STUDIES I
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search